Digital Sponsored AI-enabled pharmacovigilance, with Updesh Dosanjh Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.
Digital Sponsored From Automation to Decision Intelligence: The Next Operating... In this free white paper, IQVIA experts and thought leaders explore the real challenges and bottlenecks in pharmacovigilance today.
Patients Why patient safety doesn't end at approval Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
R&D A practical route through regulatory uncertainty in clinical... Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.
News Parexel buys Vitrana to boost patient safety toolkit Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.
News EVERSANA unveils new AI-powered pharmacovigilance suite EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.